Researchers identify genomic signature in some aggressive prostate tumors

A key challenge health care providers face in treating prostate cancer is distinguishing aggressive, potentially life-threatening tumors from curable, less aggressive tumors. NHGRI researchers and their collaborators have identified a specific genomic signature of some aggressive prostate tumors, which may help pinpoint specific treatment options. Findings from the study were published April 14 online in The American Journal of Human Genetics.
Source: NHGRI Homepage Highlights - Category: Genetics & Stem Cells Source Type: news